Literature DB >> 17312223

The immunomodulatory effect of sevoflurane in endotoxin-injured alveolar epithelial cells.

Dominik Suter1, Donat R Spahn, Stephan Blumenthal, Livia Reyes, Christa Booy, Birgit Roth Z'graggen, Beatrice Beck-Schimmer.   

Abstract

BACKGROUND: Endotoxin-induced lung injury is a useful experimental system for the characterization of immunopathologic mechanisms in acute lung injury. Although alveolar epithelial cells (AEC) are directly exposed to volatile anesthetics, there is limited information about the effect of anesthetics on these cells. In this study we investigated the effect of pretreatment with the inhaled anesthetic sevoflurane on lipopolysaccharide (LPS)-injured AEC.
METHODS: AEC were incubated with 1.1 vol % sevoflurane for 0.5 h, followed by LPS stimulation for 5 h. Expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1beta (MIP-1beta), macrophage inflammatory protein-2 (MIP-2), cytokine-induced neutrophil chemoattractant-1 (CINC-1), and intercellular adhesion molecule-1 (ICAM-1) was analyzed. In addition, functional tests were performed through chemotaxis and adherence assays to underline the biological relevance of the findings.
RESULTS: Exposure of AEC to sevoflurane resulted in a 50% downregulation of MCP-1 protein in the sevoflurane-LPS group when compared with non-sevoflurane- LPS cells (P < 0.05). MIP-1beta concentration in LPS-stimulated cells decreased by 32% with sevoflurane (P < 0.05), MIP-2 by 29% (P < 0.05), and CINC-1 by 20% (P < 0.05). ICAM-1 protein expression was attenuated by 36% (P < 0.05). This inhibition caused substantial changes in the inflammatory response of neutrophils. 33% less chemotactic activity was seen in sevoflurane-treated LPS cells (P < 0.001) as well as 47% decreased adhesion of neutrophils to AEC (P < 0.001).
CONCLUSIONS: This study shows that sevoflurane alters the LPS-induced inflammatory response, not only with respect to the expression pattern of inflammatory mediators, but also regarding the biological consequences with less accumulation of effector cells such as neutrophils.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312223     DOI: 10.1213/01.ane.0000255046.06058.58

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  22 in total

1.  Effects of sevoflurane and propofol on pulmonary inflammatory responses during lung resection.

Authors:  Yusuke Sugasawa; Keisuke Yamaguchi; Seiichiro Kumakura; Taisuke Murakami; Kenji Suzuki; Isao Nagaoka; Eiichi Inada
Journal:  J Anesth       Date:  2011-10-07       Impact factor: 2.078

2.  Effects of volatile vs. propofol-based intravenous anesthetics on the alveolar inflammatory responses to one-lung ventilation: a meta-analysis of randomized controlled trials.

Authors:  Bin Sun; Jinfeng Wang; Lulong Bo; Yan Zang; Haihui Gu; Jinbao Li; Baohua Qian
Journal:  J Anesth       Date:  2015-02-26       Impact factor: 2.078

3.  Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema.

Authors:  M Schläpfer; A C Leutert; S Voigtsberger; R A Lachmann; C Booy; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

4.  In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells.

Authors:  Raïko Blondonnet; Bertille Paquette; Damien Richard; Rémi Bourg; Géraldine Laplace; Romain Segurel; Henria Pouvelle; Corinne Belville; Loic Blanchon; Thomas Godet; Jean-Michel Constantin; Jean-Etienne Bazin; Vincent Sapin; Matthieu Jabaudon
Journal:  J Vis Exp       Date:  2018-10-23       Impact factor: 1.355

5.  The volatile anaesthetic sevoflurane attenuates lipopolysaccharide-induced injury in alveolar macrophages.

Authors:  M Steurer; M Schläpfer; M Steurer; B Roth Z'graggen; C Booy; L Reyes; D R Spahn; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2008-11-20       Impact factor: 4.330

6.  Sevoflurane anesthetic preconditioning protects the lung endothelial glycocalyx from ischemia reperfusion injury in an experimental lung autotransplant model.

Authors:  Javier Casanova; Carlos Simon; Elena Vara; Guillermo Sanchez; Lisa Rancan; Selma Abubakra; Alberto Calvo; Francisco Jose Gonzalez; Ignacio Garutti
Journal:  J Anesth       Date:  2016-06-02       Impact factor: 2.078

7.  Sevoflurane Promotes Bactericidal Properties of Macrophages through Enhanced Inducible Nitric Oxide Synthase Expression in Male Mice.

Authors:  Thomas J Gerber; Valérie C O Fehr; Suellen D S Oliveira; Guochang Hu; Randal Dull; Marcelo G Bonini; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Anesthesiology       Date:  2019-12       Impact factor: 7.892

8.  Volatile anaesthetic for treatment of respiratory failure from status asthmaticus requiring extracorporeal membrane oxygenation.

Authors:  Joseph E LaGrew; Kevin Robert Olsen; Amanda Frantz
Journal:  BMJ Case Rep       Date:  2020-01-15

9.  The Effects of Sevoflurane vs. Propofol for Inflammatory Responses in Patients Undergoing Lung Resection: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Jing-Li Yuan; Kang Kang; Bing Li; Jie Lu; Meng-Rong Miao; Xia Kang; Jia-Qiang Zhang; Wei Zhang
Journal:  Front Surg       Date:  2021-07-02

10.  Effects of sevoflurane postconditioning on cell death, inflammation and TLR expression in human endothelial cells exposed to LPS.

Authors:  Raquel Rodríguez-González; Aurora Baluja; Sonia Veiras Del Río; Alfonso Rodríguez; Jaime Rodríguez; Manuel Taboada; David Brea; Julián Álvarez
Journal:  J Transl Med       Date:  2013-04-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.